Author:
Olschewski M.,Scheurlen H.
Abstract
SummaryIf in a clinical trial only few patients consent to randomization, all those patients meeting the clinical inclusion criteria should be considered for analysis. Prerandomization is shown to be efficient only if patients can be persuaded to accept the prescribed therapy and do not introduce a self-selection bias. Under full informed consent conditions, as, for example, in a breast preservation trial, the first requirement must be questioned for ethical, the second one for methodological reasons. Conventionally randomized trials with the inclusion of patients having therapeutic preferences appear to be preferable. We briefly discuss the way of analysing the data from such a cohort study.
Subject
Health Information Management,Advanced and Specialized Nursing,Health Informatics
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献